Premier Biomedical, Inc.
Industry
- Pharmaceuticals
Latest on Premier Biomedical, Inc.
IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc
IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc
Company Changes ALATARIS , Kostantinos, PhD To: Zosano Pharma Corp. , Pres. & COO (September) From: IRRAS AB, Exec. Chairman Phone: 510-745-1200 BARTH , Neil M., MD To: Veracyte Inc. , CMO
Company Changes AGRAWAL , Amit To: Bellerophon Therapeutics Inc. , COO (July) From: Amgen Inc., Dir., Strategy & Corp. Dev. Phone: 908-574-4770 ARMOUR , Alison A., MD To: Endocyte Inc. , C